SilicoPharm
CEO. Sangho Ji, Ph.D.
Revolutionizing biomedical research and healthcare with omics foundation AI.
#AI, #Bio #Foundation_Model
Company Info.
Main Product/Service. KnockG
Date of Establishment. -
Contact Info.
Name. Taehyeong Kim, Ph.D., CTO
E-mail. taehyeongkim@silicopharm.com
Tel. +82-10-5137-5124
+82-53-614-0721
Company Profile
Revolutionizing biomedical research and healthcare with omics foundation AI.
Product / Service
What makes us different
SilicoPharm is an AI-driven startup founded by graduate researchers from DGIST, collaborating with institutions such as the Korea Brain Research Institute and Kyungpook National University Hospital to develop and validate omics foundation models.
The company has secured over USD 11 million in funding and demonstrated efficacy across more than six diseases, establishing a strong competitive edge.
Work Experience
2025
2024
2023
2022
2021
Conducted PoC with Oracle (AI LLM Startup Program)
Selected for Deep-Tech Startup Commercialization Program (R&D funding of KRW 300M)
Signed MOU with Korea Brain Research Institute / Initiated ALS (Lou Gehrig’s disease) joint research
Jan / Selected for Samsung Electronics–Daegu Center for Creative Economy & Innovation C-Lab Program
Jul / Incorporated SilicoPharm Inc.
Sep / Secured SEED investment / Selected for TIPS Program (USD ~4M equivalent R&D funding: KRW 500M)